We read with interest the comprehensive review by Chan et al. 1, "Imaging Evaluation for Steatotic Liver Disease."The authors provide a clear and timely synthesis of principles, performance characteristics, and evolving roles of ultrasound, CT, and MRI use in noninvasive assessment of hepatic steatosis and fibrosis.The discussion addresses emerging directions, including machine-learning-based techniques, opportunistic screening strategies, efforts to standardize imaging guidance, and implications of imaging use in treatment decision-making.We offer several clarifications and suggestions to further enhance the clinical applicability and translational impact of the presented concepts.First, additional emphasis on measurement harmonization and minimum reporting standards may help mitigate real-world variability,
Guo et al. (Thu,) studied this question.